Automated External Defibrillators (AED) Market Report 2026

The automated external defibrillators (aed) market size has grown strongly in recent years. It will grow from $1.98 billion in 2025 to $2.12 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to increasing cases of sudden cardiac arrest, rising installation of aeds in public places, early regulatory support for emergency preparedness, growth in hospital emergency equipment adoption, development of portable defibrillation technologies.

The automated external defibrillators (aed) market size is expected to see strong growth in the next few years. It will grow to $2.67 billion in 2030 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to expansion of smart healthcare infrastructure, rising demand for wearable aed devices, increasing government mandates for public access aeds, technological advancements in automated defibrillation, growing awareness programs for cardiac emergency response. Major trends in the forecast period include rising integration of AI guided defibrillation assistance, increasing adoption of connected and smart aed devices, growing use of remote monitoring and cloud based analytics, advancements in battery efficiency and rapid charging systems, expansion of automated emergency response technologies.

The increasing occurrence of cardiac arrests is anticipated to drive the growth of the automated external defibrillator (AED) market in the coming years. Cardiac arrest is a sudden, life-threatening condition in which the heart either stops beating or beats irregularly, hindering its ability to pump blood effectively to the body. Automated external defibrillators (AEDs) are utilized to treat cardiac arrests by delivering an electric shock to the heart, helping to restore a normal rhythm when abnormalities arise. For instance, a report published by the British Heart Foundation (BHF), a UK-based charity that funds research and promotes awareness of heart and circulatory diseases, indicated in September 2024 that around 7.6 million individuals in the UK are impacted by heart and circulatory diseases. It is projected that by 2030, the number of people living with these conditions in the UK could rise by an additional 1 million, and by 2040, this figure may increase by 2 million. Consequently, the growing incidence of cardiac arrest is fueling the expansion of the automated external defibrillator (AED) market.

Major companies in the automated external defibrillator (AED) market are prioritizing technological advancements, such as REALConnect technology, to provide reliable services. REALConnect is a software platform leveraging cellular, WiFi, GPS, and Bluetooth connectivity to enable seamless communication between devices. In January 2023, Avive Solutions Inc., a US-based technology company specializing in AED development, launched the Avive Connect AED, an FDA-approved device featuring cellular and WiFi connectivity, GPS technology, remote maintenance, and portability. This innovation exemplifies the commitment of market leaders to advancing AED technology and improving patient outcomes during cardiac emergencies.

In March 2023, SafeLife Inc., a Sweden-based company specializing in automated external defibrillators, acquired Coro Medical LLC for an undisclosed amount. This acquisition allows SafeLife Inc. to integrate advanced automated external defibrillator (AED) management services into its offerings and expand its operations in the United States, thereby reinforcing its position in the life-saving equipment sector nationwide. Coro Medical LLC is a US-based customer-focused company that provides automated external defibrillators.

Major companies operating in the automated external defibrillators (aed) market are Koninklijke Philips N.V., Asahi Kasei Corporation, Nihon Kohden Corporation, Schiller AG, Stryker Corporation, Biotronik SE & Co. KG, BPL Medical Technologies, CU Medical System Inc., Mindray Bio-Medical Electronics Co. Ltd, ViVest Medical Technology Co. Ltd, AMI Italia S.r.l., Physio-Control Corporation, CardiAid Inc., Kestra Medical Technologies Inc., DefiSign Life Systems Inc., Progetti S.r.l., MRL Inc., HeartSine Technologies Inc., M&B Electronic Instruments Inc., Instramed Inc., Metrax GmbH.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs on medical electronic components, lithium batteries, and semiconductor parts used in AEDs have increased manufacturing and import costs, particularly affecting fully automatic and connected AED systems in regions dependent on foreign supplies. Public access settings and emergency medical service providers experience the greatest impact due to large volume purchases. However, tariffs are also encouraging domestic production, boosting local component sourcing, and driving innovation in cost efficient AED designs, which may support long term market resilience.

The automated external defibrillators (AED) market research report is one of a series of new reports that provides automated external defibrillators (AED) market statistics, including automated external defibrillators (AED) industry global market size, regional shares, competitors with a automated external defibrillators (AED) market share, detailed automated external defibrillators (AED) market segments, market trends and opportunities, and any further data you may need to thrive in the automated external defibrillators (AED) industry. This automated external defibrillators (AED) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

An automated external defibrillator (AED) is a portable medical device specifically designed to analyze the electrical activity of the heart and, if necessary, deliver an electrical shock to restore a normal heart rhythm in the event of sudden cardiac arrest (SCA). AEDs are crucial in cases of life-threatening cardiac arrhythmias, significantly increasing the chances of survival for individuals experiencing sudden cardiac arrest before professional medical help arrives.

The main types of automated external defibrillators are wearable and non-wearable. A wearable AED is designed to detect abnormal heart rhythms and automatically administer an electric shock to restore the heart's normal rhythm. These devices come in various technology types, including semi-automatic and fully automatic, with different size options such as standard and pediatric. AEDs are utilized for various patient types, including adults and children, and are employed by various end-users such as hospitals, public access settings, homecare settings, pre-hospital care, emergency medical service providers, and others.North America was the largest region in the automated external defibrillator market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated external defibrillators (aed) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the automated external defibrillators (aed) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The automated external defibrillator (AED) market consists of revenues earned by entities by providing services such as maintenance and monitoring, emergency response planning and deployment services, and rental services. The market value includes the value of related goods sold by the service provider or included within the service offering. The automated external defibrillator (AED) market also includes sales of HeartStart automated external defibrillator (AED), Cardiac Science automated external defibrillator (AED), and HeartSine automated external defibrillator (AED). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.